Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RENALIT-COMBI
- Development stage
- Unknown
- Lead developer
- Bio-STILOGIT Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
RENALIT-COMBI is a dietary supplement (integratore alimentare) developed and marketed by the Italian company Bio-STILOGIT Pharmaceuticals. It is specifically formulated for the management and prevention of renal lithiasis (kidney stones) and the maintenance of urinary tract health. The product contains a combination of potassium citrate, magnesium citrate, and an extract of *Phyllanthus niruri* (commonly known as "stone breaker"). The citrate salts function as urinary alkalinizers and inhibitors of calcium stone formation by increasing urinary pH and complexing with calcium ions, which reduces the supersaturation of calcium oxalate and phosphate. *Phyllanthus niruri* is included for its anti-lithogenic properties, which include interfering with the early stages of stone formation and aggregation, as well as providing antispasmodic effects on the urinary tract to facilitate the expulsion of calculi.
- Brand names
- RENALIT-COMBI
- Other names
- Renalit Combi
Beyond the preview
Go deeper on RENALIT-COMBI.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RENALIT-COMBI.